Psychotherapy and Psychosomatics

Guidi J.a· Fava G.A.b

Author affiliations

aDepartment of Psychology “Renzo Canestrari”, University of Bologna, Bologna, Italy
bDepartment of Psychiatry, University at Buffalo, State University of New York, Buffalo, NY, USA

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: March 16, 2022
Accepted: March 23, 2022
Published online: April 14, 2022

Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 1

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS

Abstract

Euthymia is a trans-diagnostic construct characterized by lack of mood disturbances; presence of positive affect; balance of psychological well-being dimensions, flexibility, consistency, and resistance to stress. The aim of this critical review is to draw a conceptual map of euthymia. Relationships with other constructs, continuum between euthymia and dysthymia with discomfort as an intermediate area, associations with lifestyle, clinimetric assessment, role of psychotherapeutic interventions, establishment of therapeutic targets, and neurobiological mechanisms are discussed. The model is based on the bipolar nature of well-being dimensions. Euthymia means using allostasis optimally and maintaining a healthy balance that promotes positive aspects of brain and body health through health-promoting behaviors. It may provide a framework for a renewed definition of recovery, for measuring treatment outcome and for targeting interventions, including the sequential administration of therapeutic components. Clinical assessment requires a clinimetric approach encompassing a broad range of aspects, such as allostatic load and lifestyle behaviors, all interacting with each other and contributing to the euthymia/dysthymia balance. Clinimetric indices for assessing euthymia (the Clinical Interview for Euthymia and the Euthymia Scale) and related constructs (the Clinical Interview for Dysthymia and the Semi-Structured Interview for the Diagnostic Criteria for Psychosomatic Research) are presented here. Well-Being Therapy, a psychotherapeutic strategy specifically aimed at pursuing euthymia, relies on self-observation of well-being episodes using a structured diary as a distinct therapeutic ingredient. The clinical science of euthymia may unravel innovative approaches to assessment and treatment of psychiatric and medical disorders, according to a unitary conceptual framework.

© 2022 S. Karger AG, Basel

References Blumberg HP. Euthymia, depression, and mania: what do we know about the switch? Biol Psychiatry. 2012 Apr;71(7):570–1. Martini DJ, Strejilevich SA, Marengo E, Ibanez A, Scapola M, Igoa A. Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder. J Affect Disord. 2014;167:118–24. Canales-Rodriguez EJ, Pomarol-Clotet E, Radua J, Sarro S, Alonso-Lana S, Del Mar Bonnin C, et al. Structural abnormalities in bipolar euthymia: a multicontrast molecular diffusion imaging study. Biol Psychiatry. 2014 Aug;76(3):239–48. Hannestad JO, Cosgrove KP, Dellagioia NF, Perkins E, Bois F, Bhagwagar Z, et al. Changes in the cholinergic system between bipolar depression and euthymia as measured with [123I]5IA single photon emission computed tomography. Biol Psychiatry. 2013 Nov;74(10):768–76. Rocha PM, Neves FS, Corrêa H. Significant sleep disturbances in euthymic bipolar patients. Compr Psychiatry. 2013 Oct;54(7):1003–8. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002 Jun;59(6):530–7. Dunner DL. Duration of periods of euthymia in patients with dysthymic disorder. Am J Psychiatry. 1999 Dec;156(12):1992–3. Fava GA. Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med. 1999 Jan;29(1):47–61. Fava GA, Molnar G, Spinks M, Loretan A, Edwards L, Morphy MA. Case report of prolactin and bipolar illness: a longitudinal study. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(4):451–7. Fava GA, Bech P. The concept of euthymia. Psychother Psychosom. 2016;85(1):1–5. Fava GA, Guidi J. The pursuit of euthymia. World Psychiatry. 2020 Feb;19(1):40–50. MacLeod A. Euthymia: why it really does matter. World Psychiatry. 2020 Feb;19(1):1–2. Guidi J, Fava GA. The emerging role of euthymia in psychotherapy research and practice. Clin Psychol Rev. 2020 Dec;82:101941. Wood AM, Tarrier N. Positive clinical psychology: a new vision and strategy for integrated research and practice. Clin Psychol Rev. 2010 Nov;30(7):819–29. Ryan RM, Deci EL. On happiness and human potential: a review of research on hedonic and eudaimonic well-being. Annu Rev Psychol. 2001;52:141–66. Garamoni GL, Reynolds CF III, Thase ME. The balance of positive and negative affect in major depression: a further test of the states of the mind model. Psychiatry Res. 1991 Nov;39(2):99–108. Fava GA, Kellner R. Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand. 1993 Apr;87(4):225. Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013;82(1):20–34. Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167–76. Benasi G, Fava GA, Rafanelli C. Kellner’s Symptom Questionnaire, a highly sensitive patient-reported outcome measure: systematic review of clinimetric properties. Psychother Psychosom. 2020;89(2):74–89. Diener E. Subjective well-being. Psychol Bull. 1984 May;95(3):542–75. Jahoda M. Current concepts of positive mental health. New York: Basic Books; 1958. Ryff CD. Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychother Psychosom. 2014;83(1):10–28. Fava GA, Rafanelli C, Tomba E. The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry. 2012 Feb;73(2):177–84. Cosci F. Clinimetric perspectives in clinical psychology and psychiatry. Psychother Psychosom. 2021;90(4):217–21. Slater E, Slater P. A heuristic theory of neurosis. J Neurol Psychiatry. 1944 Jan;7(1-2):49–55. Tyrer P, Seivewright N, Ferguson B, Tyrer J. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psychiatr Scand. 1992 Mar;85(3):201–6. Tyrer P, Tyrer H, Guo B. The general neurotic syndrome: a re-evaluation. Psychother Psychosom. 2016;85(4):193–7. Kashdan TB, Rottenberg J. Psychological flexibility as a fundamental aspect of health. Clin Psychol Rev. 2010 Nov;30(7):865–78. Eysenck HJ. The scientific study of personality. London: Routledge & Kegan; 1952. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013. Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother Psychosom. 2017;86(1):13–30. de Figueiredo JM, Frank JD. Subjective incompetence, the clinical hallmark of demoralization. Compr Psychiatry. 1982 Jul–Aug;23(4):353–63. Marks I, Lader M. Anxiety states (anxiety neurosis): a review. J Nerv Ment Dis. 1973 Jan;156(1):3–18. Fava GA, Tomba E, Brakemeier EL, Carrozzino D, Cosci F, Eory A, et al. Mental pain as a transdiagnostic patient-reported outcome measure. Psychother Psychosom. 2019;88(6):341–9. Guidi J, Piolanti A, Gostoli S, Schamong I, Brakemeier EL. Mental pain and euthymia as transdiagnostic clinimetric indices in primary care. Psychother Psychosom. 2019;88(4):252–3. Fava GA, McEwen BS, Guidi J, Gostoli S, Offidani E, Sonino N. Clinical characterization of allostatic overload. Psychoneuroendocrinology. 2019 Oct;108:94–101. Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021;90(1):11–27. Fava GA, Rafanelli C, Tomba E, Guidi J, Grandi S. The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom. 2011;80(3):136–43. Tomba E, Rafanelli C, Grandi S, Guidi J, Fava GA. Clinical configuration of cyclothymic disturbances. J Affect Disord. 2012 Aug;139(3):244–9. Curran D. The differentiation of neuroses and manic-depressive psychoses. J Ment Sci. 1937 Mar;83(343):156–74. Bech P. Measurement of psychological distress and well-being. Psychother Psychosom. 1990;54(2–3):77–89. Thunedborg K, Black CH, Bech P. Beyond the Hamilton depression scores in long-term treatment of manic-melancholic patients: prediction of recurrence of depression by quality of life measurements. Psychother Psychosom. 1995;64(3–4):131–40. Keyes CL, Dhingra SS, Simoes EJ. Change in level of positive mental health as a predictor of future risk of mental illness. Am J Public Health. 2010 Dec;100(12):2366–71. Engel GL. A unified concept of health and disease. IRE Trans Med Electron. 1960;ME-7:48–57. Guidi J, Fava GA, Bech P, Paykel E. The Clinical Interview for Depression: a comprehensive review of studies and clinimetric properties. Psychother Psychosom. 2011;80(1):10–27. Fava GA. Discontinuing antidepressant medications. Oxford: Oxford University Press; 2021. Zhu B, Kohn R, Patel A, Koo BB, Louis ED, de Figueiredo JM. Demoralization and quality of life of patients with Parkinson disease. Psychother Psychosom. 2021;90(6):415–21. Rippe JM. Are we ready to practice lifestyle medicine? Am J Med. 2019 Jan;132(1):6–8. Tomba E. Assessment of lifestyle in relation to health. In: Fava GA, Sonino N, Wise TN, editors. The psychosomatic assessment. Basel: Karger; 2012. 32. p. 72–96. Shonkoff JP, Boyce WT, McEwen BS. Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention. JAMA. 2009 Jun;301(21):2252–9. Holt RIG. The management of obesity in people with severe mental illness: an unresolved conundrum. Psychother Psychosom. 2019;88(6):327–32. McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Intern Med. 1993 Sep;153(18):2093–101. Juster RP, Bizik G, Picard M, Arsenault-Lapierre G, Sindi S, Trepanier L, et al. A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development. Dev Psychopathol. 2011 Aug;23(3):725–76. McEwen BS. The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry. 2020 Feb;19(1):57–8. Guidi J, Rafanelli C, Fava GA. The clinical role of well-being therapy. Nord J Psychiatry. 2018 Aug;72(6):447–53. Fava GA. Well-being therapy. Treatment manual and clinical applications. Basel: Karger; 2016. Guidi J, Fava GA. Conceptual and clinical innovations of well-being therapy. J Cogn Ther. 2021;14(1):196–208. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004 Oct;161(10):1872–6. Rafanelli C, Gostoli S, Buzzichelli S, Guidi J, Sirri L, Gallo P, et al. Sequential combination of cognitive-behavioral treatment and well-being therapy in depressed patients with acute coronary syndromes: a randomized controlled trial (TREATED-ACS Study). Psychother Psychosom. 2020;89(6):345–56. Feinstein AR. Clinimetrics. New Haven: Yale University Press; 1987. Emmelkamp PMG, Bouman TK, Scholing A. Anxiety disorders. Chichester: Wiley; 1993. Fava GA. Forty years of clinimetrics. Psychother Psychosom. 2022;91(1):1–7. Fava GA, Belaise C. A discussion on the role of clinimetrics and the misleading effects of psychometric theory. J Clin Epidemiol. 2005 Aug;58(8):753–6. Carrozzino D, Patierno C, Guidi J, Berrocal Montiel C, Cao J, Charlson ME, et al. Clinimetric criteria for patient-reported outcome measures. Psychother Psychosom. 2021;90(4):222–32. Carrozzino D, Svicher A, Patierno C, Berrocal C, Cosci F. The euthymia scale: a clinimetric analysis. Psychother Psychosom. 2019;88(2):119–21. Sonino N, Fava GA. A simple instrument for assessing stress in clinical practice. Postgrad Med J. 1998 Jul;74(873):408–10. Piolanti A, Offidani O, Guidi J, Gostoli S, Fava GA, Sonino N. Use of the psychosocial index (PSI): a sensitive tool in research and practice. Psychother Psychosom. 2016;85(6):337–45. Svicher A, Romanazzo S, De Cesaris F, Benemei S, Geppetti P, Cosci F. Mental pain questionnaire: an item response theory analysis. J Affect Disord. 2019 Apr;249:226–33. Wright JH, Brown GK, Thase ME, Ramirez-Basco M. Learning cognitive-behavior therapy. 2nd ed. Arlington: American Psychiatric Association Publishing; 2017. Fava GA, Grandi S, Canestrari R, Grasso P, Pesarin F. Mechanisms of change of panic attacks with exposure treatment of agoraphobia. J Affect Disord. 1991;22(1–2):65–71. Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression. New York: Guilford; 2002. Hayes SC, Strosahal K, Wilson KG. Acceptance and commitment therapy. New York: Guilford Press; 1999. Pennebaker JW, Evans JF. Expressive writing: words that heal. Enumclaw: Idyll Arbor; 2014. Frankl VE. The will to meaning: foundations and applications of logotherapy. New York: World Publishing; 1969. Enright RD, Fitzgibbons RP. Forgiveness therapy. Washington: American Psychological Association; 2014. Gilbert P. Compassion focused therapy: distinctive features. London: Routledge; 2010. Radstaak M, Hüning L, Bohlmeijer ET. Well-being therapy as rehabilitation therapy for posttraumatic stress disorder symptoms: a randomized controlled trial. J Trauma Stress. 2020 Oct;33(5):813–23. Fava GA, Guidi J. When the label does not match the content of a trial: “Well-Being Therapy” in posttraumatic stress disorder: commentary on Radstaak et al. (2020). J Trauma Stress. 2021 Apr;34(2):467–9. Fava GA. The concept of recovery in affective disorders. Psychother Psychosom. 1996;65(1):2–13. Fava GA. Sequential treatment: a new way of integrating pharmacotherapy and psychotherapy. Psychother Psychosom. 1999;68(5):227–9. Guidi J, Fava GA. Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2021 Mar;78(3):261–9. Sterling P. Allostasis: a model of predictive regulation. Physiol Behav. 2012 Apr;106(1):5–15. Schulkin J, Sterling P. Allostasis: a brain-centered, predictive mode of physiological regulation. Trends Neurosci. 2019 Oct;42(10):740–52. Cosci F, Mansueto G, Fava GA. Relapse prevention in recurrent major depressive disorder. A comparison of different treatment options based on clinical experience and a critical review of the literature. Int J Psychiatry Clin Pract. 2020 Nov;24(4):341–8. McEwen BS, Nasca C, Gray JD. Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 2016 Jan;41(1):3–23. McEwen BS. Epigenetic interactions and the brain-body communication. Psychother Psychosom. 2017;86(1):1–4. Fava GA, Guidi J, Grandi S, Hasler G. The missing link between clinical states and biomarkers in mental disorders. Psychother Psychosom. 2014;83(3):136–41. Horwitz RI, Singer BH, Hayes-Conroy, Cullen MR, Mawn M, Colella K, et al. Biosocial pathogenesis. Psychother Psychosom. 2022;91(2):73–7. Article / Publication Details

First-Page Preview

Received: March 16, 2022
Accepted: March 23, 2022
Published online: April 14, 2022

Number of Print Pages: 12
Number of Figures: 4
Number of Tables: 1

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.